Home
Dupixent

Dupixent Market Share Analysis for June 2026

learn more about dupixent® (dupilumab), a prescription medicine fda-approved to treat six conditions. see how dupixent® may help. serious side effects can occur. please see important safety information and prescribing information and patient information on website.

Health > Pharmacy

Domaindupixenthcp.com

Year Founded2017

Employees51 - 200

Annual Revenue$10M - $15M

Dupixent

Dupixent (including company regionals)

dupixenthcp.com

See more website traffic and engagement information

Dupixent Revenue up to June 2026 is 10M - 15M

revenue generated by Dupixent top domains

Dupixent top domains revenue over 3 years

Revenue for Dupixent top domains

dupixenthcp.com10M - 15M

See more with Sales Intelligence

Total visits to Dupixent's top domains

Understand Dupixent market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

dupixenthcp.com101.9K

See more with Sales Intelligence

Avg. visit duration in Dupixent's top domains

Analyze Dupixent engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

dupixenthcp.com00:01:24

See more with Sales Intelligence

Avg. pageviews on Dupixent's top domains

See how Dupixent keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

dupixenthcp.com1.67

See more with Sales Intelligence

Dupixent top competitors by domain

Top similar sites in June 2026, ranked by their affinity

dupixent.comCompany NameDupixentEmployees51 - 200HQUnited States, North Carolina, CharlotteAnnual revenue$10M - $15MTotal visits591.8KHealth > Pharmacy

Top technologies used by Dupixent

These are the website technologies, by industry, used by Dupixent top domains

Advertising (15)

DoubleClick

Conversion & Analytics (12)

Google Analytics

Marketing (4)

Google Marketing Platform

Audio Video Media (3)

Vimeo

More Technologies

10

See all

News & Signals from Dupixent

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDupixent launched CREXONT (carbidopa on Sep 23rd '24.BRIDGEWATER, N.J.-(BUSINESS WIRE)-Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") today announced that it has launched CREXONT(R) (carbidopa and levodopa) extended-release capsules for the treatment of Parkinson's disease.